PharmaCon 2015

The emerging pharmaceutical markets of Asia are expected, with a few exceptions, to grow this year and beyond, most providing attractive platforms for investments in the local industries.

Thailand has one of the best outlooks because it has positioned itself as an entry point to the more remote countries of Southeast Asia. Vietnam's pharma market also is expected to grow because of its expanding and aging population. Cambodia's market will continue to be constrained, but improve gradually as it builds its program of universal healthcare through 2025 . Sri Lanka is expected to have stronger opportunities as it shifts its focus to chronic diseases, but its own price caps, plus a reliance on foreign aid, could limit returns on investments in the local industry. The pharmaceutical market in Singapore is valued at almost $1 billion. The country's healthcare system was ranked #6 worldwide by the World Health Organization (WHO).